Roger Packer, M.D., Senior Vice President for the Center of Neuroscience and Behavioral Medicine and Director of the Gilbert Neurofibromatosis Institute at Children’s National Health System, was an invited speaker at the 2016 Neurobiology of Disease in Children Symposium: Neurofibromatosis (NF). This conference brought together experts from around the world to discuss the newest developments in the understanding and treatment of children with NF. While at the conference, which was held on October 26, 2016, Dr. Packer gave an update of the Department of Defense-sponsored Neurofibromatosis Clinical Trial Consortium. The Neurofibromatosis Clinical Trials Consortium, of which Dr. Packer is the group chair, was established by the Department of Defense Neurofibromatosis Research Program to develop and perform clinical trials for the treatment of NF complications in children and adults.
You might also like
LATEST TWEETS FROM INNOVATION DISTRICT
Proud of all of the great things we have accomplished this year at @ChildrensNatl and the Children's National #Research Institute. We have remained steadfast in our commitment to #children and will keep working hard to help them #GROWUPSTRONGER.
The Children’s National Research Institute Annual Report is here! Read about all the research and education that went on in 2019-2020: https://innovationdistrict.childrensnational.org/childrens-national-research-institute-releases-annual-report/?utm_source=twitter&utm_medium=social&utm_campaign=cnri_annualreport